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Abstract While the immune microenvironment has been
investigated in breast cancers, little is known about its role
in non-malignant breast tissues. Here we quantify and
localize cellular immune components in normal breast
tissue lobules, with and without visible immune infiltrates
(lobulitis). Up to ten representative lobules each in eleven
normal breast tissue samples were assessed for B cells
(CD20), cytotoxic T cells (CD8), helper T cells (CD4),
dendritic cells (CD11c), leukocytes (CD45), and mono-
cytes/macrophages (CD68). Using digital image analysis,
immune cell densities were measured and compared
between lobules with/without lobulitis. 109 lobules in 11
normal breast tissue samples were evaluated; 31 with
lobulitis and 78 without. Immune cells showed consistent
patterns in all normal samples, predominantly localized to
lobules rather than stroma. Regardless of lobulitis status,
most lobules demonstrated CD8?, CD11c?, CD45?, and
CD68? cells, with lower densities of CD4? and CD20?
cells. Both CD11c? and CD8? cells were consistently and
intimately associated with the basal aspect of lobule epi-
thelium. Significantly higher densities of CD4?, CD8?,
CD20?, and CD45? cells were observed in lobules with
lobulitis. In contrast, densities of monocytes/macrophages
and dendritic cells did not vary with lobulitis. In normal
breast tissue, myeloid and lymphoid cells are present and
localized to lobules, with cytotoxic T and dendritic cells
directly integrated with epithelium. Lobules with lobulitis
have significantly more adaptive immune (B and T) cells,
but no increase in dendritic cells or monocytes/macro-
phages. These findings indicate an active and dynamic
mucosal immune system in normal breast tissue.
Keywords Immune cell  Breast lobules  Lobulitis 
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Introduction
The role of interactions between epithelial cells, fibro-
blasts, and adipocytes in normal mammary gland function
has been extensively investigated; however, the role of the
immune system in maintaining the mammary gland is less
understood. The immune system is known to play key roles
during mammary gland branching morphogenesis, lacta-
tion, post-lactational involution, and breast cancer pro-
gression [1–3]. During lactation, secretory IgA targeted
against infectious agents is produced in breast milk,
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providing a surrogate immune system during the first few
weeks of life of the infant [4, 5] and mucosal immunity
protects the mammary gland from microbial infection
(mastitis) [6]. During post-lactational involution, both mast
cells and macrophages are key mediators of glandular
regression [7, 8]. Immune cell function has also been
extensively linked to progression of breast cancer [9–11].
While much of our knowledge about the specific roles of
immune cells in the mammary gland have been derived
from studies using experimental animals, these have
glandular organization distinct from the human breast [12],
and very little is known about baseline levels of immune
cells in normal, non-malignant human breast tissue in the
quiescent, non-lactating state from which most breast
cancers develop.
Mucosal immunity develops at interfaces between the
external environment and body tissues. In the gut, antigenic
exposures from food and microorganisms shape the
mucosal immune system [13], and the interaction of diet,
intestinal microbiota, and mucosal immunity play a key
role in the development of colorectal cancer [14] and ex-
traintestinal neoplasms [15]. There are corollaries between
intestinal mucosal immunity and that of the breast. For
example, just as there are commensal organisms in the gut,
lactobacilli species have been identified in lactating breasts
[16], and may have a role in recovery from mastitis [17].
Given the role of aberrant gut mucosal immunity on car-
cinogenesis, it is possible that mucosal immunity of the
breast can also affect the development of breast neoplasms.
We have previously identified histologic features of
premalignant and normal breast tissue that are associated
with increased breast cancer risk [18, 19]. We have found
that age-related lobular involution of breast lobules (the
natural regression of breast epithelium over time, distinct
from post-lactational involution) is associated with
decreased breast cancer risk [20, 21]. In a recent compar-
ison of normal breast tissues versus those showing benign
breast disease [22], we observed that immune infiltrates
were common in lobules of normal breast tissue. Here, we
examined the immune microenvironment in normal human
breast tissues to define the baseline state of immune cell
presence in the non-lactational adult state.
Methods
Tissue samples
Approval was obtained from the Institutional Review
Board to conduct this research. Normal breast tissue sam-
ples were obtained from the Komen Tissue Bank at the
Indiana University Simon Cancer Center [23]. From a
large sample of 455 normal breast tissues previously
characterized histologically for epithelial abnormalities and
age-related involution [22], we selected a small number of
samples for an intensive study to quantitate immune cells
of various types within breast tissue lobules. In order to
evaluate differences between samples with and without
lobulitis, we selected samples to represent both strata of
lobulitis categories (present versus absent). Age-related
involution of lobules is a histologic feature associated with
breast cancer risk; with lower risk seen in samples with
smaller, more completely involuted lobules [20, 21].
Therefore, in order to evaluate lobules representing dif-
ferent states of age-related involution, we also stratified the
sample selection by involution categories [minimal invo-
lution (1–24 %), partial involution (25–74 %), and com-
plete involution (C75 %)]. From prior review of these
normal specimens [22], we had data on the number of
lobules within each specimen, and we selected samples
with an adequate number of lobules to evaluate (8 or
more). Thus, among 107 samples meeting these criteria, we
randomly selected two samples from each of 6 categories
defined by involution status and lobulitis. One category
(lobulitis absent and minimal involution) had only 1 sam-
ple, resulting in a total of 11 samples selected for the final
study group. These eleven samples underwent multiple
immunostains and comprised our analysis sample for this
descriptive study. Tissue sections from each sample
underwent one H&E stain and the following immunostains:
CD45 (leukocytes), CD20 (B cells), CD4 (helper T cells),
CD8 (cytotoxic T cells), CD11c (dendritic cells), and
CD68 (monocytes/macrophages). Two positive control
tissues representing non-malignant states with immune
infiltrates underwent the same immunostains (resolving
lactation [24, 25] and diabetic mastopathy [26, 27]).
Histologic review
H&E slides were reviewed by the study pathologist. Up to
10 representative lobules from each tissue sample were
selected for individual analysis. Lobulitis was defined on a
per lobule basis as an immune cell infiltrate involving a
lobule in which the intralobular stroma showed readily
identifiable lymphocyte nuclei by H&E staining at low
magnification (409), and at least 4 lymphocytes between
the adjacent acini at higher magnification (4009) (Fig. 1).
The study pathologist, with other members of the team,
reviewed immunostains at low and high power for locali-
zation of immune cells. Selected lobules were digitally
annotated (see ‘‘Slide digitization and lobule annotation’’
section below) for quantification of immune cell densities.
For illustrative purposes (see Figures), photomicrographs
of representative lobules at 4009 magnification were
obtained using an Olympus 400 camera attached to a
microscope.
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Immunohistochemical staining
Immunohistochemical staining procedures were described
previously [28]. For immunostains [CD4 (Leica Novocas-
tra NCL-CD4-368-L-CE at 1/50), CD8 (DAKO M7103 at
1/20), CD11c (Leica Novocastra NCL-L-CD11c-563 at
1/25), CD20 (DAKO M0755at 1/60), CD45(DAKO M0710
at 1/1500), and CD68 (DAKO, M0876 at 1/100)], anti-
bodies were prepared at stated dilutions and slides were
incubated for 30 min at room temperature.
Slide digitization and lobule annotation
Whole slide digital images of each breast biopsy sample
(H&E and immunostains) were captured with the Aperio
Scanscope XT slide scanner (Aperio Technologies) using
the 209 objective lens. The digital images were analyzed
using Aperio ImageScope software (http://www.aperio.
com/pathology-services/imagescope-slide-viewing-software.
asp). Quantitative image analysis was performed using
Spectrum version 11, based on the FDA-approved algo-
rithms supplied by the manufacturer with modifications as
described below. Using the digitized images, lobules were
selected by the pathologist from the H&E slide, circled, and
numerically labeled. For each immunostain on a given
sample, the corresponding (same) lobules identified on the
H&E slide were identified on the successive immunostain
sections, similarly circled, and assigned the corresponding
lobule number. The area of each circled lobule was calcu-
lated by Spectrum.
Digital image analysis and cell counts
After lobule annotation, positively stained cells were
counted using Spectrum software (Aperio Technologies).
The manufacturer’s FDA-approved algorithms were used
with customization of the parameters as follows: for each
immunostain, a lobule was selected that had distinct posi-
tive and negative cells. Initially, the nuclear algorithm was
used to distinguish stained from unstained cells. A digital
color overlay was reviewed with the pathologist to deter-
mine concordance between algorithm and breast patholo-
gist. The algorithm settings were then adjusted iteratively
until the capture of positive cells was optimized. The
algorithm was then applied to another lobule from a dif-
ferent sample to confirm the optimization. Once optimized,
the algorithm for each immunostain was then applied
uniformly to all circled lobules for that immunostain on all
samples, and positively stained cells were recorded on a
per lobule basis for each sample. For the dendritic cell
immunostain, CD11c was measured as a ratio of positive to
total pixels due to a more diffuse pattern of particle
staining (Fig. 2). For the CD45 immunostain, more
extensive cell counting analysis was performed to deter-
mine the density of positively stained cells within lobules
versus in the remaining breast tissue. Therefore, for CD45
sections, every lobule was circled and the entire tissue
section also was outlined. The CD45 cell count algorithm
was then applied separately to the entire tissue section and
all of the circled lobules; cell counts and areas for all
lobules were then subtracted from cell counts and areas of
Fig. 1 The presence of immune infiltrates that define lobulitis. a Normal lobule, without lobulitis; b normal lobule, with lobulitis. H&E stain,
9200 magnification
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the entire section to obtain cell density for the extralobular
breast tissue.
Statistical analysis
Cell densities were calculated as the number of positively
stained cells per mm2 for all immunostains except
CD11c for which positive:total pixel ratio was calculated.
Immunostain results were compared between groups of
lobules with and without lobulitis using linear mixed
effects regression to account for multiple lobules from
each patient and to evaluate potential confounding by
age. Square root transformation was used for cell density
and pixel ratio data where appropriate. An a priori two-
tailed alpha level of 0.05 was used for statistical
significance.
Fig. 2 Quantification of immune cells in normal lobules. a, b CD8?
cell quantitation in a normal lobule without lobulitis. a immunostain
alone, b color overlay demonstrating positively stained cells within
circled lobule; positive cells are identified by red and orange color,
yellow cells are below staining threshold for positivity, and blue cells
are non-staining cells. c, d CD11c quantitation by pixel count ratio in
a normal lobule without lobulitis, 9200 magnification. c Immunostain
alone, d color overlay demonstrating pixels with positive staining
(red and orange) compared to non-stained pixels (blue). 9200
magnification
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The within-sample variance of cell densities and pixel
ratio was evaluated for each immunostain using intraclass
correlation coefficients (ICC). ICC values [0.50 would
indicate that the variance between subjects is greater than
the variance within subjects while values \0.50 would
indicate that the variance between subjects is less than the
variance within subjects. The within-sample coefficients of
variation (100 9 (SD/Mean)) were also calculated and
summarized across samples for each immunostain.
Results
Characteristics of normal tissue donors and samples
Normal tissue samples were obtained from women with
median age 45 (range 24–63) at the time of tissue
donation. Of 11 normal breast tissue samples studied, one
had fewer than 10 lobules present (9 lobules). In total, per
lobule data comprised 109 lobules: 96 (88 %) normal
lobules, 11 non-proliferative fibrocystic lobules, and 2
proliferative fibrocystic lobules. Lobules represented the
spectrum of age-related lobular involution, with 10
(10 %) having no age-related lobular involution, 49
(51 %) with partial involution, and 37 (39 %) with
complete lobular involution; involution status is not
applicable to fibrocystic lobules and is therefore missing
for the 13 fibrocystic lobules.
Lobulitis
For the 109 lobules evaluated, 31 lobules showed lobulitis
and 78 did not. Two samples had no lobulitis present in any
lobules, six had lobulitis in less than half of the studied
lobules, and three had lobulitis in half or more of the
lobules. The presence of lobulitis varied by age-related
lobular involution status of the lobules at 70, 43, and 3 %
in the none, partial, and complete lobular involution cate-
gories, respectively. In accordance with these findings,
there was a moderate negative correlation (r = -0.49)
between age and percent of lobules with lobulitis.
Immune cells in normal breast tissues are primarily
confined to breast lobules
Immune cells were present in consistent patterns in all
samples and were predominantly localized to breast lobules
rather than stroma and fat. This was confirmed quantita-
tively by CD45 (leukocyte) counts. Across all samples,
median CD45 cell density was 261.3 cells/mm2 among
lobules with lobulitis and 122.9 cells/mm2 among lobules
without lobulitis (p \ 0.0001), compared to only 15.4
cells/mm2 in extralobular breast tissue.
Immune cell subgroups in lobules and association
with lobulitis
Immune cells of various types were present in the vast
majority of lobules, regardless of lobulitis status (Fig. 3).
Among the immune cell subgroups, CD8? and CD68?
cells were the most numerous across lobules; compara-
tively, densities of CD4? cells and CD20? cells were
lower. Significantly higher cell densities of CD4, CD8,
CD20, and CD45 cell types were observed in lobules with
lobulitis compared to lobules without lobulitis (Table 1). In
contrast, the densities of monocytes/macrophages and
dendritic cells did not vary significantly with the presence
of lobulitis. Positive controls had higher median densities
of all immune cell types compared to normal samples,
except CD8? cell density which was fairly similar in both
groups (Table 1). Very few lobules had no immune cells
(i.e., immune cell density value of 0) for CD8, CD45, and
CD68 cell types (Table 2). Virtually all lobules demon-
strated CD11c? cells (100 % of lobules) and CD8? cells
(99 % of lobules). In contrast, CD4? cells and CD20?
cells were more likely to be completely absent from lobules
(and this was more frequent in lobules without lobulitis
compared to those with lobulitis).
Intraepithelial immune cells
Regardless of whether immune infiltrates were observed on
H&E stain, immunostains confirmed that in all samples at
high magnification power, both dendritic cells and CD8?
cells are consistently observed in intimate association with
the epithelium of lobular acini and are primarily located at
the basal aspect of the epithelium (Fig. 4).
Variation in immune cell densities
between and within subjects
Intraclass correlation coefficients demonstrated values
\0.50 for all immunostains (other than CD20 which was
0.51), indicating that the variance in immune cell densities
between subjects was less than the variance within sub-
jects, indicating heterogeneity across lobules within a
patient (Table 3). The within-sample coefficients of vari-
ation also demonstrate substantial within-sample variabil-
ity with respect to immune cell densities, with medians
ranging from 42 to 182 %.
Discussion
In this study, we found that immune cells are (1) a con-
sistent part of normal breast tissue, (2) primarily localized
to breast lobules, (3) closely associated with the breast
Breast Cancer Res Treat (2014) 144:539–549 543
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epithelium, and (4) vary substantially across lobules within
a woman and between different women. Lobules with
immune infiltrates visualized on H&E stain do have
quantitatively higher densities of adaptive immune cells
(helper T cells, cytotoxic T cells, and B cells) compared to
lobules without lobulitis, while innate immune components
(dendritic cells and monocytes/macrophages) do not appear
to vary between lobules with and without lobulitis. Even
among lobules without visible immune infiltrates, dendritic
cells and cytotoxic T cells are uniformly present and are
located in close association with the epithelium. Taken
together, these findings indicate that immune cells are
present in the normal condition and that immune infiltrates
detected on H&E stain are not necessarily pathologic but
Fig. 3 Quantitative immune cell densities for individual lobules in
each of the 11 subjects studied; open circles indicate lobules without
lobulitis, and crosses indicate lobules with lobulitis. Asterisk in CD8
density plot denotes one point outside the plotting region for subject
#10 (value was 1336 CD8 cells/mm2)
Table 1 Density of immune cells in normal breast tissues and benign positive controls
Cell type Normal samples (11 subjects) Positive controls (2 subjects)
Lobules with lobulitis
N = 31 lobules
Lobules without lobulitis




N = 10 lobules
Diabetic mastopathy
N = 10 lobules
Median (IQR) Median (IQR) Median (IQR) Median (IQR)
CD4 (cells/mm2) 61.9 (25.0, 80.2) 27.3 (0, 101.2) 0.0001 185 (120, 1,057) 750 (160, 2,336)
CD8 (cells/mm2) 381.5 (307.2, 567.7) 216.3 (145.8, 303.0) \0.0001 395 (177, 697) 465 (196, 551)
CD20 (cells/mm2) 20.0 (3.8, 151.2) 0 (0, 19.1) 0.003 60 (33, 262) 2,510 (269, 3,664)
CD45 (cells/mm2) 261.3 (169.4, 351.2) 122.9 (81.4, 179.9) \0.0001 615 (511, 1,762) 3,872 (1,171, 4,719)
CD68 (cells/mm2) 210.1 (103.1, 268.3) 192.8 (113.1, 263.8) 0.41 1,822 (1,412, 2,100) 2,003 (1,573, 2,308)
CD11c pixel ratio
(positive/total)
0.03 (0.02, 0.04) 0.02 (0.01, 0.04) 0.11 0.20 (0.14, 0.29) 0.19 (0.14, 0.27)
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may represent the higher range of immune cell density that
is present to some degree in almost all normal lobules.
This is the first study to evaluate normal human breast
tissue samples and to quantify basic populations of immune
cells in the breast epithelium in the normal non-lactating
state. Strengths of the study include the use of breast tissues
from normal donors, evaluation of multiple immune cell
types, and quantitative data on immune cell densities. Our
finding of a nearly universal presence of CD8? and
CD11c? immune cells in breast lobules provides insight
and raises questions regarding the role of the immune
system in its intimate association with the breast epithe-
lium. A mucosal immune system in breast tissue may exist
primarily as a defense against microbes [16, 17], although
active tumor immunosurveillance is another possible
function [29, 30]. Therefore, our finding of an active
mucosal immune system in breast tissue has possible far-
reaching implications for breast carcinogenesis and
prevention.
In the gut, another mucosal tissue for which the role of
immune cell function has been more extensively studied,
T and B cells are abundant and are intimately associated
with the epithelial cells. In the lamina propria, immediately
below the epithelial basement membrane, T cells pre-
dominate and differ from peripheral T cells by showing
clonality for local antigen exposure [31, 32]. In addition to
the lamina propria T cells, intraepithelial lymphocytes
(IELs) accumulate directly in the epithelial plane [33, 34].
Table 2 Number and percentage of lobules with a value of 0 for
various immune cell types








N % N % N %
CD4 24 22.0 23 29.5 1 3.2
CD8 1 0.9 1 1.3 0 0
CD20 54 49.5 47 60.3 7 22.6
CD45 3 2.8 3 3.8 0 0
CD68 5 4.6 5 6.4 0 0
CD11c 0 0 0 0 0 0
Fig. 4 Direct association of dendritic cells and CD8 T cells within epithelium. a CD8 positive cells located at the basal aspect of the epithelium,
b CD11c positive staining extending more diffusely around epithelium. 9400 magnification
Table 3 Variation in immune cell densities between and within subjects
Cell type Between-subject variance Within-subject variance ICC CV median (range)
CD4 (cells/mm2) 3,001.17 4,440.53 0.403 84 % (40–139 %)
CD8 (cells/mm2) 17,468.78 26,572.44 0.397 51 % (15–78 %)
CD20 (cells/mm2) 3,736.08 3,517.39 0.515 182 % (65–316 %)
CD45 (cells/mm2) 2,696.35 11,552.14 0.189 65 % (37–83 %)
CD68 (cells/mm2) 3,252.43 10,558.04 0.236 42 % (21–116 %)
CD11c pixel ratio (positive/total) 0.0001179 0.0001736 0.404 43 % (18–76 %)
Intraclass correlation coefficient (ICC) is the ratio of the between-subject variance to the total variance (i.e., the proportion of the total variance
representing between-subject variance); values [0.50 would indicate that the variance between subjects was greater than the variance within
subjects while values \0.50 would indicate that the variance between subjects was less than the variance within subjects
Coefficient of variation (CV) is the ratio of the standard deviation divided by the mean. Within-sample CVs were calculated and then
summarized over all samples
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Gut IELs are more frequently CD8? T cells with cytolytic
properties [35], which may play important roles in tissue
repair as well as pathogen defense [36, 37]. We observed
heterogeneity in immune cells across lobules within indi-
vidual subjects. Heterogeneity of the mucosal immune
system in the gut is highly compartmentalized across dif-
ferent sites and also within sites [38, 39], thought to reflect
prior exposure to microbes [40] and unique immunological
needs of the tissue based on function. It has been proposed
that a primary responsibility of CD8 IELs is to survey for
stress in the epithelium and to control immune responses
[41]. We found CD8? T cells and CD11c? dendritic cells
directly associated with mammary epithelium in all lob-
ules, suggesting a similar potential function in the mam-
mary gland.
This consistent presence of CD8? cells and dendritic
cells, interspersed within the breast epithelium, strongly
suggests a role for antigen presentation and immune
effector function, as well as stress response and mainte-
nance of epithelial integrity. An even more intriguing
possibility is that the mucosal immune system in the breast
may serve a critical role in tumor immunosurveillance,
supported by the previously established role for both CD8
T cells and dendritic cells in this process [42]. The concept
of immunity against cancer was first suggested by Ehrlich
in 1909 [43], with dramatic increases in supporting evi-
dence in recent years [29, 30]. In the realm of breast can-
cer, there is some epidemiologic evidence for spontaneous
regression of human breast cancers, supporting the possi-
bility of an immune presence for the purpose of immuno-
surveillance [44]. If functional breast mucosal immunity
exists, then quantitative profiles of immune cells in breast
tissue may be predictive of breast cancer risk. Furthermore,
the presence of a breast mucosal immune system supports
the possibility of immune modulation for cancer preven-
tion, including vaccines for breast cancer prevention.
Prior studies have evaluated immune cells in breast tissue
but most have focused on specific disrupted tissue states,
including cancer, post-lactational involution [24, 25], and
diabetic mastopathy [26]. Reports on the prognostic signif-
icance of immune infiltrates in breast cancers have varied
results, with some studies showing that leukocyte infiltration
is associated with improved survival [45, 46] and others
showing worse survival [47]. Immune cell infiltrates and
types have also been implicated in breast cancer progression,
metastasis, and response to chemotherapy [9–11]. Fewer
studies have evaluated immune cells in non-cancerous breast
tissue, usually as a comparison group for malignant tumor
tissue [48–51]. Immunohistochemical comparisons of
immune infiltrates in breast cancer tissues versus tissues
from women with benign breast disease or reduction mam-
moplasty have consistently demonstrated that CD8? lym-
phocytes represent the predominant immune cell infiltrate in
breast cancers and are less frequent in non-malignant breast
tissue [48, 49]. One group reported a depletion of immune
cells from the malignant epithelium, with localization to
stroma and more than doubling of the CD4:CD8 ratio in
malignant versus benign tissue [49]. In contrast, benign
breast tissues demonstrated greater accumulation of immune
cells in the epithelium, also with a CD8? predominance [48,
49]. A more recent study demonstrated a greater accumula-
tion of leukocytes in breast cancer tissue compared to non-
adjacent breast tissue from the same woman [51], finding no
difference in CD8? cells in tumor tissue versus surrounding
non-neoplastic breast tissue. A weakness of these prior
studies is the use of samples with benign breast disease or
reduction mammoplasty tissues, which have significant
histologic differences from the normal state [22]. Breast
tissues from women with benign breast disease differ sig-
nificantly from normal breast tissues in histologic features of
both epithelial proliferation and lobular involution [22], two
features strongly related to breast cancer risk [18, 20].
Therefore, benign breast disease tissues may not provide the
optimal source of tissues for understanding the immune
microenvironment in the normal state.
Limitations of our study include a small number of
samples, a consequence of our approach to obtain an
intensive and detailed quantitation of multiple immune cell
types. Therefore, our study cannot evaluate associations of
immune cell profiles with other established breast cancer
risk factors, including BMI, family history, and meno-
pausal status [52–55]. Work is currently underway to
evaluate more qualitative measures of immune cell profiles
with BMI and other features of breast cancer risk. Another
possible limitation is our definition of lobulitis, based upon
the assessment of the breast pathologist to denote the
minimum threshold of whether an immune cell infiltrate
was present. We are aware of two published studies that
define lobulitis using a cutoff number of lymphocytes per
lobule (on H&E stain). One study used a criterion of[100
lymphocytes per lobule [56], and another used a criterion of
[50 lymphocytes (moderate) or [100 lymphocytes
(marked) [57]. As per the methods sections in these studies,
it appears that they did not actually individually count the
cells in each lobule, suggesting a more qualitative judge-
ment of the number of lymphocytes present. This made
sense in those situations because individual counting would
be impractical to implement on the larger sample sets in
those studies. We believe our definition is advantageous,
especially since it is supported by our quantitative findings
confirming higher leukocyte density (CD45) in lobules
with lobulitis versus those without. Furthermore, the simple
cutoff used in earlier studies does not account for the size
of the lobule; smaller lobules with equal percentage
immune infiltrate will have fewer lymphocytes, which
could lead to incorrect assessment of lobulitis in smaller
546 Breast Cancer Res Treat (2014) 144:539–549
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lobules and create bias in lobule selection by eliminating
evaluation of small involuted lobules. Our definition allows
for assignment of lobulitis, effective for any lobule size.
Conclusion
In summary, we find that in normal breast tissues, myeloid
and lymphoid immune cells are present and predominantly
localized to breast lobules rather than the interlobular
stroma. Furthermore, CD8? cells and dendritic cells are
directly integrated with breast epithelium, indicating the
presence of a mucosal immune system in human non-lac-
tating female breast tissue. These findings suggest that
there is a role for antigen presentation and orchestrated
cytotoxic functionality within the epithelium. Additional
studies are necessary to define specific functional roles of
immune cells in the breast epithelium; however, the iden-
tification of these immune effectors indicates that immune
infrastructure is present within breast epithelium to make a
breast cancer prevention vaccine possible. If unique anti-
gens could be identified for epithelial cells with early
malignant change or fusion proteins unique to breast can-
cer, T cell recognition could be induced via a vaccine
approach. Work is currently underway to improve our
understanding of how lobulitis relates to age and lobular
involution (factors proven to be associated with breast
cancer risk), as well as whether quantitative immune cell
densities are associated with breast cancer risk.
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